News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PanGenex Corporation Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients


11/18/2009 11:02:51 AM

TAMPA, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets: PGCX) (“PanGenex” or “the Company”) announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES